Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Mulet-Lazaro

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Hemasphere|November 13, 2023
From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in HematopoiesisRoger Mulet-Lazaro, Ruud Delwel
Blood Cancer Discovery|August 2, 2024
Oncogenic Enhancers in LeukemiaRoger Mulet-Lazaro, Ruud Delwel
Blood Cancer Discovery|April 16, 2025
One for All and All for One: New Insights into Enhancers Driving MYC DysregulationRoger Mulet-Lazaro, Ruud Delwel
International Journal of Cancer|September 30, 2021
Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotypeClaudia Gebhard, Roger Mulet-Lazaro, Dagmar Glatz, et al.
Blood Advances|November 23, 2021
Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null miceRoberto Avellino, Roger Mulet-Lazaro, Marije Havermans, et al.
Blood|April 8, 2021
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AMLRoger Mulet-Lazaro, Stanley van Herk, Claudia Erpelinck, et al.
Science Advances|May 15, 2024
Oncogene <i>EVI1</i> drives acute myeloid leukemia via a targetable interaction with CTBP2Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, et al.
Leukemia|November 21, 2024
The co-receptor Neuropilin-1 enhances proliferation in inv(16) acute myeloid leukemia via VEGF signalingMahesh Hegde, Mohd H Ahmad, Roger Mulet Lazaro, et al.
Blood|March 29, 2020
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemiaSophie Ottema, Roger Mulet-Lazaro, H Berna Beverloo, et al.
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Hemasphere|November 13, 2023
From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in HematopoiesisRoger Mulet-Lazaro, Ruud Delwel
Blood Cancer Discovery|August 2, 2024
Oncogenic Enhancers in LeukemiaRoger Mulet-Lazaro, Ruud Delwel
Blood Cancer Discovery|April 16, 2025
One for All and All for One: New Insights into Enhancers Driving MYC DysregulationRoger Mulet-Lazaro, Ruud Delwel
International Journal of Cancer|September 30, 2021
Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotypeClaudia Gebhard, Roger Mulet-Lazaro, Dagmar Glatz, et al.
Blood Advances|November 23, 2021
Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null miceRoberto Avellino, Roger Mulet-Lazaro, Marije Havermans, et al.
Blood|April 8, 2021
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AMLRoger Mulet-Lazaro, Stanley van Herk, Claudia Erpelinck, et al.
Science Advances|May 15, 2024
Oncogene <i>EVI1</i> drives acute myeloid leukemia via a targetable interaction with CTBP2Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, et al.
Leukemia|November 21, 2024
The co-receptor Neuropilin-1 enhances proliferation in inv(16) acute myeloid leukemia via VEGF signalingMahesh Hegde, Mohd H Ahmad, Roger Mulet Lazaro, et al.
Blood|March 29, 2020
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemiaSophie Ottema, Roger Mulet-Lazaro, H Berna Beverloo, et al.
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Pageof 3